Long-term Consequences of Helicobacter pylori Eradication: Clinical Aspects

References

• Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1–3
   PubMed Web of Science ®Google Scholar
• Labenz J, Börsch G. Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. Am J Gastroenterol 1995; 90: 692–t
   PubMedGoogle Scholar
• Graham D Y, Lew G M, Evans D G, Evans D J, Klein P D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 216–19
   Google Scholar
• Hentschel E, Brandstätter G, Dragosics B, Hirschl A M, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
   PubMed Web of Science ®Google Scholar
• Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19–22
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut 1993; 34: 466–9
   PubMed Web of Science ®Google Scholar
• Hosking S W, Ling T KW, Chung S CS, Cheng A FB, Sung J JY, Li A KC. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508–10
   PubMed Web of Science ®Google Scholar
• Sung J Y, Chung S CS, Ling T KW, Li K K, Yung M Y, Leung V KS, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139–42
   PubMed Web of Science ®Google Scholar
• Coghlan J G, Gilligan D, Humphreys H, McKenna D, Dooley C, Sweeney E, et al. Campylobacter pylori and recurrence of duodenal ulcer—a 12 month follow-up study. Lancet 1987; 2: 1109–11
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359–68
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M, Harrison G, Rameh B, Weil J, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86: 375–82
   PubMedGoogle Scholar
• Xia H X, Marshall D G, Windier H J, Smyth C J, Keane C T, O'Morain C. Recrudescence of Helicobacter pylori after apparent eradication in duodenal ulcer patients. Am J Gastroenterol 1994; 89: 1391.
   Google Scholar
• Forbes G M, Glaser M E, Cullen D JE, Warren J R, Christiansen K J, Marshall B J, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258–60
   PubMed Web of Science ®Google Scholar
• Borody T, Andrews P, Mangus N, Jankiewicz E, Brandl S. Helicobacter pylori reinfection 4 years post-eradication. Lancet 1992; 339: 1295
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Blaser M J, Pérez-Pérez G I, Hargrett-Bean N, Tauxe R V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41–6
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U. Helicobacter pylori: reinfection after apparent eradication—the Ipswich experience. Scand J Gastroenterol 1996; 31(Suppl 215)96–104
   Web of Science ®Google Scholar
• Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994; 29: 874–9
   PubMed Web of Science ®Google Scholar
• Sonnenberg A. The costs of duodenal ulcer treatment with antibiotics. Gastroenterology 1994; 106: A28.
   PubMedGoogle Scholar
• Unge P, Stålhammar N O. The cost-effectiveness of Helicobacter pylori eradication vs. maintenance treatment in duodenal ulcer patients—the case of Sweden. Gastroenterology 1994; 106: A32
   Google Scholar
• Powell K U, Bell G D, Bolton G H, Burridge S M, Bowden A F, Rameh B, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994; 87: 283–90
   PubMedGoogle Scholar
• Egan J V, Jensen D M. Long-term management of patients with bleeding ulcers. Rationale, results, and economic impact. Gastrointest Endosc Clin North Am 1991; l: 367–85
   Google Scholar
• Ell C, Hagenmüller F, Schmitt W, Riemann J F, Hahn E G, Hohenberger W. Multizentrische prospektive Untersuchung zum aktuellen Stand der Therapie der Ulkusblutung in Deutschland. Dtsch Med Wschr 1995; 120: 3–9
   PubMed Web of Science ®Google Scholar
• Jensen D, Cheng S, Kovacs T OG, Randall G, Jensen M E, Reedy T, et al. A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. N Engl J Med 1994; 330: 382–6
   PubMed Web of Science ®Google Scholar
• Graham D Y, Hepps K S, Ramirez F C, Lew G M, Saeed Z A. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939–42
   PubMed Web of Science ®Google Scholar
• Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar C H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest Endosc 1995; 41: 5–7
   PubMed Web of Science ®Google Scholar
• Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19–23
   PubMed Web of Science ®Google Scholar
• Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1–4
   PubMed Web of Science ®Google Scholar
• Santander C, Perez-Miranda M, Gomez Cedenilla A, Carpintero P, Grávalos R G, Pajares J M. Helicobacter pylori eradication vs maintenance therapy for the prevention of recurrent bleeding from duodenal ulcer. Gut 1994; 35(Suppl 5)S17
   Google Scholar
• Cullen D JE, Hawkey G M, Humphries H, Cave R, Shepherd V, Logan R PA, et al. Role of non-steroidal anti-inflammatory drugs and Helicobacter pylori in bleeding peptic ulcers. Gastroenterology 1994; 106: A66
   Google Scholar
• Lanas A, Sekar M C, Hirschowitz B I. Objective evidence of aspirin in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862–9
   PubMed Web of Science ®Google Scholar
• El Omar E, Penman I, Ardill J ES, McColl K EL. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534–8
   PubMedGoogle Scholar
• Talley N J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174–83
   PubMed Web of Science ®Google Scholar
• McCarthy C, Patchett S, Collins R M, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114–19
   PubMed Web of Science ®Google Scholar
• Yamada T, Ahnen D, Alpers D H, Greenberg H B, Gray L, Joscelyn K B, et al. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
   PubMed Web of Science ®Google Scholar
• Phull P S, Halliday D, Price A B, Jacyna M R. Is absence of dyspeptic symptoms a useful test to assess H. pylori eradication?. Gut 1995; 36(Suppl 1)A12
   PubMedGoogle Scholar